每年專案
指紋
查看啟用 病理部 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
概要
專案
- 1 已完成
-
台灣國中生期望-價值-成本模式的建構、發展歷程與其前因後果變項的考驗：潛在成長模式與教學實驗取向
Peng, S.-L. (PI)
21-08-01 → 22-07-31
研究計畫: Research project
-
Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma (Journal of Experimental & Clinical Cancer Research, (2022), 41, 1, (220), 10.1186/s13046-022-02429-8)
Chien, C. H., Yang, W. B., Chuang, J. Y., Lee, J. S., Liao, W. A., Huang, C. Y., Chen, P. Y., Wu, A. C., Yang, S. T., Lai, C. C., Chi, P. I., Chu, J. M., Cheng, S. M., Liu, C. C., Hwang, D. Y., Chen, S. H. & Chang, K. Y., 2025 12月, 於: Journal of Experimental and Clinical Cancer Research. 44, 1, 179.研究成果: Comment/debate › 同行評審
開啟存取 -
Corrigendum to “Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway—a translational study” [Free Radic. Biol. Medi. 208 (2023) 103–111, (S0891584923005853), (10.1016/j.freeradbiomed.2023.08.013)]
Chang, W. T., Wu, C. C., Liao, I. C., Lin, Y. W., Chen, Y. C., Ho, C. H., Lee, W. C., Lin, Y. C., Chen, Z. C., Shih, J. Y., Wu, N. C. & Kan, W. C., 2025 6月, 於: Free Radical Biology and Medicine. 233, p. 422-423 2 p.研究成果: Comment/debate › 同行評審
-
HIV-negative primary effusion lymphoma: a series of seven cases
Chu, C. Y., Thingujam, B., Wang, S. H., Chen, Y. P., Cheng, H. Y., Medeiros, L. J. & Chang, K. C., 2025 9月, 於: Histopathology. 87, 3, p. 397-407 11 p.研究成果: Article › 同行評審